News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
815,392 Results
Type
Article (75452)
Company Profile (698)
Press Release (739242)
Section
Business (230596)
Career Advice (3748)
Deals (39458)
Drug Delivery (122)
Drug Development (89827)
Employer Resources (194)
FDA (17860)
Job Trends (17151)
News (391863)
Policy (38968)
Tag
Academia (2974)
Alliances (56239)
Alzheimer's disease (1367)
Approvals (17782)
Artificial intelligence (173)
Bankruptcy (393)
Best Places to Work (12572)
Biotechnology (479)
Breast cancer (200)
Cancer (1469)
Cardiovascular disease (126)
Career advice (3192)
Cell therapy (319)
Clinical research (71379)
Collaboration (526)
Compensation (269)
COVID-19 (2814)
C-suite (121)
Data (1428)
Diabetes (192)
Diagnostics (6711)
Earnings (94175)
Employer resources (167)
Events (126858)
Executive appointments (415)
FDA (18570)
Funding (455)
Gene therapy (221)
GLP-1 (720)
Government (5012)
Healthcare (20735)
Infectious disease (2915)
Inflammatory bowel disease (126)
Interviews (731)
IPO (17603)
Job creations (5054)
Job search strategy (2618)
Layoffs (494)
Legal (9920)
Lung cancer (218)
Manufacturing (235)
Medical device (14445)
Medtech (14450)
Mergers & acquisitions (21993)
Metabolic disorders (531)
Neuroscience (1724)
NextGen Class of 2024 (7622)
Non-profit (5068)
Northern California (1739)
Obesity (301)
Opinion (249)
Patents (127)
People (63863)
Pharmaceutical (142)
Phase I (22055)
Phase II (31097)
Phase III (23424)
Pipeline (532)
Postmarket research (3343)
Preclinical (9763)
Radiopharmaceuticals (258)
Rare diseases (291)
Real estate (7222)
Regulatory (25628)
Research institute (2642)
Resumes & cover letters (586)
Southern California (1508)
Startups (4224)
United States (16339)
Vaccines (668)
Weight loss (239)
Date
Today (4)
Last 7 days (631)
Last 30 days (2419)
Last 365 days (37873)
2024 (37704)
2023 (42567)
2022 (53927)
2021 (58723)
2020 (57669)
2019 (51309)
2018 (39094)
2017 (36900)
2016 (37898)
2015 (43972)
2014 (38916)
2013 (35113)
2012 (37133)
2011 (37289)
2010 (37082)
Location
Africa (1193)
Arizona (231)
Asia (48236)
Australia (8305)
California (4035)
Canada (1474)
China (321)
Colorado (184)
Connecticut (199)
Europe (109042)
Florida (550)
Georgia (146)
Illinois (453)
Indiana (244)
Maryland (684)
Massachusetts (3228)
Michigan (194)
Minnesota (316)
New Jersey (1161)
New York (1125)
North Carolina (881)
Northern California (1739)
Ohio (156)
Pennsylvania (953)
South America (1573)
Southern California (1508)
Texas (589)
Utah (116)
Washington State (436)
815,392 Results for "hisamitsu pharmaceutical co inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Bay
NovaBay Pharmaceuticals and Eyenovia Commence Co-Promotion Activities
NovaBay® Pharmaceuticals, Inc. and Eyenovia, Inc. have commenced activities under a previously announced co-promotion agreement.
July 1, 2024
·
8 min read
Xediton Pharmaceuticals Inc. To Present at The 2024 Bloom Burton & Co. Healthcare Investor Conference
Xediton Pharmaceuticals Inc., a leading Canadian specialty pharmaceutical company, will be participating in the 2024 Bloom Burton & Co. Healthcare Investor
April 9, 2024
·
2 min read
Press Releases
Bloom Burton & Co. Inc. Announces Changes to Holdings in Satellos Bioscience Inc.
December 20, 2024
·
2 min read
Policy
Co-Diagnostics, Inc. Submits First FDA 510(k) Application for Co-Dx PCR Pro Platform
Co-Diagnostics, Inc. announced that the Company has completed its first U.S. Food and Drug Administration application for 510 clearance for the Co-Dx™ PCR Pro™ instrument, and the Co-Dx PCR COVID-19 Test for over-the-counter use.
June 14, 2024
·
4 min read
Press Releases
Co-Diagnostics, Inc. and CoSara Diagnostics to Inaugurate New Oligo Facility
December 11, 2024
·
4 min read
Co-Diagnostics, Inc. to Participate at FIME 2024 in Miami Beach, June 19-21
Co-Diagnostics, Inc. (Nasdaq: CODX) (the “Company” or “Co-Dx”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that the Company has been invited to participate in the Utah booth at the FIME trade show in Miami Beach, Florida, on June 19-21.
June 18, 2024
·
1 min read
Career Advice
How to Deal With a Toxic Co-Worker
Dealing with a toxic co-worker can be exhausting, and it can make your workplace more stressful. There are a few ways to make it easier, including developing healthy coping mechanisms and even talking it out with your colleague.
September 25, 2024
·
5 min read
·
Alina Zahid
Business
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces Advance of $5 Million Milestone Payment from Partners Alvogen, Inc. and Lotus Pharmaceutical Co. Ltd. (1975.TW)
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) (“NRx Pharmaceuticals”, the “Company”), a clinical-stage biopharmaceutical company, today announced the advance of the first $5 million milestone payment based on the Company’s partnership agreement with Alvogen, Inc. and Lotus Pharmaceutical Co. Ltd. (1975.TW).
February 12, 2024
·
3 min read
Press Releases
Co-Diagnostics, Inc. Reports Third Quarter 2024 Financial Results
November 7, 2024
·
10 min read
Business
Pharmascience Inc. to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
Montreal, Quebec--(Newsfile Corp. - April 3, 2024) - Pharmascience Inc., the largest Canadian-owned pharmaceutical company and a leader in the Canadian generic market, will be participating in the 2024 Bloom Burton & Co
April 3, 2024
·
2 min read
1 of 81,540
Next
